Awareness and knowledge of human papillomavirus in the Swedish adult population

Journal of Adolescent Health

Volumn 50, Issue 2, 2012, Pages 204-206

  Dahlstrm, Lisen Arnheim ^a   Sundstrm, Karin ^a   Young, Cecilia ^b   Lundholm, Cecilia ^a   Sparn, Pr ^a   Tran, Trung Nam ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Sanofi Pasteur MSD   (Sweden)

Author keywords

Awareness; Cervical cancer; Condyloma; HPV; Sexually transmitted disease

Indexed keywords

ADULT; AGE; ARTICLE; AWARENESS; CONDYLOMA; CROSS-SECTIONAL STUDY; EDUCATION; FEMALE; GENDER; HUMAN; INCOME; KNOWLEDGE; MALE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; ALPHAPAPILLOMAVIRUS; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; SWEDEN; YOUNG ADULT;

EID: 84856087514     PISSN: 1054139X     EISSN: 18791972     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2011.05.009     Document Type: Article

References (9)

1. K.A. Ault Effect of prophylactic human papillomavirus l1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four randomised clinical trials Lancet 369 2007 1861 1868 (Pubitemid 46829356)
2. J. Paavonen, P. Naud, J. Salmern Efficacy of human papillomavirus (hpv)-16/18 as04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic hpv types (patricia): Final analysis of a double-blind, randomised study in young women Lancet 374 2009 301 314
3. CDC Gardasil update: Safety and efficacy in boys and men ACIP, 2009 http://www.cdc.gov/vaccines/recs/acip/downloads/mtg-slides-jun09/06-2-hpv.pdf September 20, 2009
4. N. Munoz, S.K. Kjaer, K. Sigurdsson Impact of human papillomavirus (hpv)-6/11/16/18 vaccine on all hpv-associated genital diseases in young women J Natl Cancer Inst 102 2010 325 339
5. N. Muoz, R. Manalastas Jr, P. Pitisuttithum Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: A randomised, double-blind trial Lancet 373 2009 1949 1957
6. K. Sundstrm, T.N. Tran, C. Lundholm Acceptability of hpv vaccination among young adults aged 18-30 yearsA population based survey in Sweden Vaccine 28 2010 7492 7500
7. L.A. Dahlstrom, T.N. Tran, C. Lundholm Attitudes to hpv vaccination among parents of children aged 12-15 years-a population-based survey in Sweden Int J Cancer 126 2010 500 507
8. B. Nøhr, C. Munk, L. Tryggvadottir Awareness of human papillomavirus in a cohort of nearly 70,000 women from four Nordic countries Acta Obstet Gynecol Scand 87 2008 1048 1054
9. L.A. Marlow, J. Waller, J. Wardle Public awareness that hpv is a risk factor for cervical cancer Br J Cancer 97 2007 691 694 (Pubitemid 47339895)